In gene-based tests including only high impact SNVs, the known AD risk gene ABCA7 and the potential novel gene ZNF655 reached the nominal p-value of 0.05 in meta-analysis with replication cohorts as well as in a meta-analysis of discovery and replication samples (Table 3, Supplementary Table S6). Here, ABCA7 is linked to Alzheimer disease.